OpenAI acquires biotech startup Orchestra Bio to expand its Rosalind platform with AI agents for drug development, clinical trial coordination and research workflows.
OpenAI acquires biotech startup Orchestra Bio to expand its Rosalind platform with AI agents for drug development, clinical trial coordination and research workflows.